Skip to main content

Lin Xichen's Form 4 filing

Structure Therapeutics Inc. (GPCR) · filed Aug 5, 2026

Accession no.
0001962926-26-000007
Filed
Aug 5, 2026, 4:49 PM ET
Trade date
Aug 4, 2026
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 2 non-derivative transactions and 4 derivative transactions. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lin XichenCIK 0001962926Officer (CHIEF SCIENTIFIC OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 4, 2026Ordinary SharesMOption exerciseAcquired+11,817$0.34F1+$4,017.78240,777Direct
Aug 4, 2026Ordinary SharesCConversionDisposed−11,817$0.00$0228,960Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 4, 2026Ordinary SharesMOption exerciseDisposed−11,817$0.00$0154,715Direct
Aug 4, 2026Ordinary SharesCConversionAcquired+11,817$0.00$03,939Direct
Aug 4, 2026Ordinary SharesSSaleDisposed−9,300$49.29F8,F9−$152,785.67839Direct
Aug 4, 2026Ordinary SharesSSaleDisposed−2,517$50.03F8,F10−$41,974.330Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Reflects price per share in Ordinary Shares.

Referenced by the price of 1 transaction in Table I.

F8

Reflects price per share in American Depositary Shares.

Referenced by the price of 2 transactions in Table II.

F9

The weighted average sale price for the transaction reported was $49.2857 and the range of prices were between $48.66 and $49.65. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.

Referenced by the price of 1 transaction in Table II.

F10

The weighted average sale price for the transaction reported was $50.0290, and the range of prices were between $49.69 and $50.33. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of American Depositary Shares sold at each price will be provided.

Referenced by the price of 1 transaction in Table II.

Read the full filing on SEC EDGAR (opens in a new tab)